NCT02380313 2016-10-06Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or AibrateroneGlaxoSmithKlinePhase 1 Withdrawn
NCT01663415 2012-09-17A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerAstellas Pharma IncPhase 2 Withdrawn